Done sou Salè H1B

Akèy › Anplwayè › Boehringer Ingelheim Pharmaceuticals, Inc. › Senior Scientist

Senior Scientist nan Boehringer Ingelheim Pharmaceuticals, Inc.: Salè H-1B

23 aplikasyon kondisyon travay pou tit travay Senior Scientist nan Boehringer Ingelheim Pharmaceuticals, Inc.. Salè baz medyàn ofri $129,957; mwatye mitan $125,175–$137,937.

Demann (LCA)23
Salè medyan ofri$129,957
Mwatye salè yo$125,175–$137,937
10yèm–90yèm pousantaj$120,000–$142,000

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20232$121,236
FY202416$129,062
FY20252$143,500
FY20263$142,000

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$140,500
Nivo IV
Ridgefield, CTMay 23, 2026Oct 1, 2026Certifye
$142,000
Nivo IV
Ridgefield, CTMay 8, 2026Oct 1, 2026Certifye
$145,000
Nivo II
Ridgefield, CTMay 7, 2026Sep 1, 2026Certifye
$142,000
Nivo II
Ridgefield, CTMar 5, 2025Aug 20, 2025Certifye
$145,000
Nivo II
Ridgefield, CTDec 11, 2024Dec 23, 2024Certifye
$130,000
Nivo II
Ridgefield, CTJul 3, 2024Jul 22, 2024Certifye
$135,000
Nivo II
Ridgefield, CTJun 7, 2024Oct 1, 2024Certifye
$130,889
Nivo II
Ridgefield, CTJun 6, 2024Oct 1, 2024Certifye
$120,000
Nivo II
Ridgefield, CTApr 16, 2024Aug 25, 2024Certifye
$139,794
Nivo IV
Ridgefield, CTApr 12, 2024Sep 29, 2024Certifye
$129,957
Nivo II
Ridgefield, CTApr 11, 2024Oct 1, 2024Certifye
$129,375
Nivo II
Ridgefield, CTMar 27, 2024Aug 25, 2024Certifye
$120,000
Nivo II
Ridgefield, CTMar 25, 2024Aug 25, 2024Certifye
$133,447
Nivo III
Ridgefield, CTMar 22, 2024Aug 9, 2024Certifye
$120,000
Nivo II
Ridgefield, CTMar 20, 2024Aug 28, 2024Certifye
$128,750
Nivo II
Danbury, CTMar 18, 2024Aug 28, 2024Certifye
$120,000
Nivo II
Danbury, CTMar 18, 2024Aug 20, 2024Certifye
$125,350
Nivo II
Ridgefield, CTMar 14, 2024Aug 13, 2024Certifye
$125,000
Nivo II
Ridgefield, CTMar 11, 2024Aug 20, 2024Certifye
$127,500
Nivo II
Danbury, CTMar 8, 2024Aug 20, 2024Certifye
$136,080
Nivo II
Ridgefield, CTJan 31, 2024Jun 10, 2024Certifye
$127,472
Nivo III
Ridgefield, CTMay 23, 2023Aug 3, 2023Certifye
$115,000
Nivo III
Ridgefield, CTApr 14, 2023Oct 1, 2023Certifye

Senior Scientist nan tout anplwayè yo →

Lòt travay nan Boehringer Ingelheim Pharmaceuticals, Inc.

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).